%20in%20Aesthetic%20Medicine%20with%20Gloss%20Skin%20and%20Hair%20Clinic.png)
Our speciality at Einfolge Technologies is deciphering intricate patents and turning them into workable plans that spur creativity. One such ground-breaking technology is detailed in WO2016201323A1, a patent that discloses a sophisticated exosome and lipid-based nanoparticle delivery platform. Originally designed to treat systemic diseases, this technology is now demonstrating exceptional promise in cosmetic dermatology and trichology.
Our partnership with Gloss Skin and Hair Clinic, a leader in aesthetic care, demonstrates how this innovation is not merely theoretical but is already improving patient outcomes in real time.
WO2016201323A1: Exosome-Inspired, Immune-Evasive Drug Delivery
Researchers from Stanford University are the original authors of this patent, which presents exosomes and nanoparticles that express the protein CD47, which aids in immune evasion. Among the major innovations are:
Modification of the CD47 surface to extend systemic circulation
• Active agents such as proteins, siRNA, and antibodies are encapsulated.
• Improved tissue absorption and targeted delivery without inciting an immunological reaction
This delivery method is extremely relevant to aesthetic medicine, particularly in augmenting topical and injectable treatments for skin and hair care, even though it was created for oncology and autoimmune therapy.
Exosome-Based Aesthetics at Gloss Skin and Hair Clinic
We at Gloss Skin and Hair Clinic have seen firsthand how the science underlying WO2016201323A1 can be modified for innovative cosmetic uses. Exosome and nano lipid carrier-based treatments provide:
Skin Rejuvenation
• Exosome facials to stimulate collagen and reduce signs of aging
• Advanced skin healing and revitalisation through the use of nano encapsulated growth factors; liposomal delivery of glutathione, peptides, and retinoids for brightening and anti-aging effects
Hair Repair
Using exosomes and stem cells to rejuvenate dormant hair follicles and reverse miniaturisation; using nano-PRP boosters to guarantee a continuous release of growth factors; and using liposomal minoxidil and nutraceutical blends to improve follicular absorption
These treatments align with the delivery efficiency and biological compatibility defined in the patent, reimagining the way aesthetic therapies are delivered and absorbed.
Einfolge’s Role: Bridging Patent Intelligence with Clinical Innovation
At Einfolge Technologies, our responsibilities go beyond documentation. By performing patent landscaping and freedom-to-operate (FTO) evaluations in the cosmeceuticals industry, we enable clinics like Gloss.
Examining exosome delivery patterns and associated intellectual property opportunities
• Aiding in the submission of custom patent applications to safeguard novel treatment formulations
• Offering guidance on R&D to clinic translation tactics to gain a competitive edge
The Future: IP-Driven Cosmetic Therapies
Cosmetic medicine is about to be redefined by exosomes and nanocarriers. Patents such as WO2016201323A1 pave the way for:
• Non-invasive rejuvenation
• Focused, durable therapies
• Additionally, hair treatments with clinical validation gain more scientific support and expand their commercial viability.
The incorporation of these ideas is already raising the bar for care at Gloss Skin and Hair Clinic. At Einfolge, we make sure that the intellectual property underlying these innovations is not only recognised but also utilised for long-term success.
Conclusion: Where Exosome Science Meets Aesthetic Excellence
Leading clinics like Gloss are already at the forefront of this emerging field, which combines nanotechnology, exosome delivery systems, and cosmetic dermatology. The path from patent to practice becomes a road map for industry-wide change thanks to Einfolge’s extensive IP expertise.
Please do not enter any kind of spam links ConversionConversion EmoticonEmoticon